SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,680.00    30.00 (0.53%)
Bid:
5,670.00
Ask:
5,690.00
Spread: 20.00 (0.353%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Interim Management Statement

29 Jul 2013 07:00

RNS Number : 2981K
Cranswick PLC
29 July 2013
Ā 



29 July 2013

Cranswick plc

("Cranswick" or "the Company" or "the Group")

Ā 

First quarter interim management statement

Ā 

Cranswick, the UK food producer, today provides an update on trading for the period from 1 April 2013 to 28 July 2013.

Ā 

Ā 

Current trading

Ā 

The current financial year has started in line with the Board's expectations.

Ā 

Underlying turnover in the three months to 30 June 2013 was 10 per cent ahead of the same period last year reflecting strong growth across most product categories.

Ā 

Total sales for the three months were 12 per cent higherafter taking into account the contribution from Kingston Foods which was acquired on 29 June 2012 and modest third party sales made by Wayland Farms Limited ("Wayland Farms"), formerly East Anglian Pigs Limited, which was acquired on 29 April 2013.

Ā 

Operating margins in the first quarter were below those achieved during the previous financial year as a whole, reflecting higher input costs and, as was anticipated, start-up costs at the new pastry facility.

Ā 

As expected, pig prices increased during the first quarter of the financial year and have increased further during July to a new record high. The impact has been absorbed through on-going efficiency improvements and by the strong volumes processed through the Group's facilities.

Ā 

The Group's gourmet pastry facility at Malton, North Yorkshire was completed during the period. The factory is now commissioned, enabling the Group to further develop its existing business by offering a broad range of premium savoury pastry products.

Ā 

Work has also started on extending the Delico cooked meats facility in Milton Keynes. The project will provide increased capacity to meet anticipated sales growth and the investment in advanced cooking and slicing technology will deliver increased throughput and improved yields.

Ā 

Ā 

Financial position

Ā 

Net debt stood at £55 million at the quarter-end. This level was £17 million higher than at the same time last year and compared to £20 million at 31 March 2013. The increase during the quarter reflects the usual seasonal uplift in working capital, the Group's on-going capital investment programme and the £13 million investment in Wayland Farms. The Group is in a sound financial position, with committed, unsecured facilities of £100 million which provide generous headroom going forward.

Ā 

Ā 

Board changes

Ā 

As announced on 20 May 2013, Patrick Farnsworth will stand down from his position as Non-Executive Director at today's Annual General Meeting. Kate Allum, CEO of First Milk Limited, joined the Board as a Non-Executive Director on 1 July 2013. Kate brings operational experience of international food markets and broadens the expertise and experience within the Board.

Ā 

Ā 

Ā 

Ā 

Outlook

Ā 

With experienced management at all levels of the Group, a strong range of products, a well invested asset base and a robust financial position, the Board remains confident in the continued long term success and development of the business.

Ā 

Ā 

Ā 

Enquiries:

Ā 

CityRoad Communications +44 (0) 20 7248 8010

Paul Quade +44 (0) 7947 186 694

Ā 

Ā 

Ā 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2013 showed sales of £875m and profit before tax of £47.4m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement represents Cranswick's first quarter Interim Management Statement for the period from 1 April 2013 to 28 July 2013.

4. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
IMSUNVVRORABUAR
Date   Source Headline
11th Mar 20257:05 amRNSDirectorship
5th Mar 20252:24 pmRNSTotal Voting Rights
3rd Mar 20253:27 pmRNSHolding(s) in Company
24th Feb 20254:54 pmRNSDirector/PDMR Shareholding
10th Feb 20252:51 pmRNSAdditional Listing
3rd Feb 202510:04 amRNSTotal Voting Rights
22nd Jan 20251:21 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ3 Trading Update and Acquisition of JSR Genetics
7th Jan 20254:02 pmRNSTotal Voting Rights
27th Dec 20247:00 amRNSDirector/PDMR Shareholding
11th Dec 20243:26 pmRNSHolding(s) in Company
3rd Dec 20249:53 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSINTERIM RESULTS
13th Nov 202411:41 amRNSTotal Voting Rights
1st Oct 202412:46 pmRNSTotal Voting Rights
1st Oct 202412:43 pmRNSBlock Listing LTIP return
1st Oct 202412:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 202412:38 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHalf Year Trading Update
25th Sep 20243:19 pmRNSDirector/PDMR Shareholding
16th Sep 202411:56 amRNSHolding(s) in Company
16th Sep 202411:55 amRNSHolding(s) in Company
12th Aug 202412:15 pmRNSDirector/PDMR Shareholding
6th Aug 20244:20 pmRNSDirector/PDMR Shareholding
5th Aug 202412:18 pmRNSDirector/PDMR Shareholding
5th Aug 202412:16 pmRNSDirector/PDMR Shareholding
5th Aug 202412:15 pmRNSDirector/PDMR Shareholding
5th Aug 202412:11 pmRNSDirector/PDMR Shareholding
1st Aug 202410:52 amRNSTotal Voting Rights
29th Jul 20244:02 pmRNSAGM Statement
29th Jul 20247:00 amRNSFirst quarter trading statement
3rd Jun 20249:42 amRNSTotal Voting Rights
21st May 20247:00 amRNSPreliminary Results
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSThird quarter trading statement
3rd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20243:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.